More Articles

The Dispatch E-Edition

All current subscribers have full access to Digital D, which includes the E-Edition and
unlimited premium content on Dispatch.com, BuckeyeXtra.com, BlueJacketsXtra.com and
DispatchPolitics.com.
Subscribe
today!

NEW BRUNSWICK, N.J. — Johnson & Johnson said yesterday that it’s been offered $4.15 billion
by the Carlyle Group for its Ortho-Clinical Diagnostics business, a year after J&J began
reviewing strategic options for the blood-testing unit.

J&J, based in New Brunswick, N.J., has until March 31 to decide whether to accept the
offer.

Johnson & Johnson executives plan to discuss the offer on Tuesday, when the pharmaceutical
and consumer-products company reports fourth-quarter results.